• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 - 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Molecular diagnostics - Market size and forecast 2020-2025
o Companion diagnostics - Market size and forecast 2020-2025
o Market opportunity by Product
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2020-2025
o Europe - Market size and forecast 2020-2025
o Asia - Market size and forecast 2020-2025
o ROW - Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Agilent Technologies Inc.
o bioMerieux SA
o F. Hoffmann-La Roche Ltd.
o Hologic Inc.
o Illumina Inc.
o Myriad Genetics Inc.
o QIAGEN NV
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2020 - 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 - 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2020
• 21: Product - Market share 2020-2025 (%)
• 22: Comparison by Product
• 23: Molecular diagnostics - Market size and forecast 2020-2025 ($ million)
• 24: Molecular diagnostics - Year-over-year growth 2020-2025 (%)
• 25: Companion diagnostics - Market size and forecast 2020-2025 ($ million)
• 26: Companion diagnostics - Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Product
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2020-2025 (%)
• 30: Geographic comparison
• 31: North America - Market size and forecast 2020-2025 ($ million)
• 32: North America - Year-over-year growth 2020-2025 (%)
• 33: Europe - Market size and forecast 2020-2025 ($ million)
• 34: Europe - Year-over-year growth 2020-2025 (%)
• 35: Asia - Market size and forecast 2020-2025 ($ million)
• 36: Asia - Year-over-year growth 2020-2025 (%)
• 37: ROW - Market size and forecast 2020-2025 ($ million)
• 38: ROW - Year-over-year growth 2020-2025 (%)
• 39: Key leading countries
• 40: Market opportunity By Geographical Landscape ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Abbott Laboratories - Overview
• 48: Abbott Laboratories - Business segments
• 49: Abbott Laboratories - Key offerings
• 50: Abbott Laboratories - Key customers
• 51: Abbott Laboratories - Segment focus
• 52: Agilent Technologies Inc. - Overview
• 53: Agilent Technologies Inc. - Business segments
• 54: Agilent Technologies Inc. - Key offerings
• 55: Agilent Technologies Inc. - Key customers
• 56: Agilent Technologies Inc. - Segment focus
• 57: Becton, Dickinson and Co. - Overview
• 58: Becton, Dickinson and Co. - Business segments
• 59: Becton, Dickinson and Co. - Key offerings
• 60: Becton, Dickinson and Co. - Key customers
• 61: Becton, Dickinson and Co. - Segment focus
• 62: bioMerieux SA - Overview
• 63: bioMerieux SA - Business segments
• 64: bioMerieux SA - Key offerings
• 65: bioMerieux SA - Key customers
• 66: bioMerieux SA - Segment focus
• 67: F. Hoffmann-La Roche Ltd. - Overview
• 68: F. Hoffmann-La Roche Ltd. - Business segments
• 69: F. Hoffmann-La Roche Ltd. - Key offerings
• 70: F. Hoffmann-La Roche Ltd. - Key customers
• 71: F. Hoffmann-La Roche Ltd. - Segment focus
• 72: Hologic Inc. - Overview
• 73: Hologic Inc. - Business segments
• 74: Hologic Inc. - Key offerings
• 75: Hologic Inc. - Key customers
• 76: Hologic Inc. - Segment focus
• 77: Illumina Inc. - Overview
• 78: Illumina Inc. - Product and service
• 79: Illumina Inc. - Key offerings
• 80: Illumina Inc. - Key customers
• 81: Illumina Inc. - Segment focus
• 82: Myriad Genetics Inc. - Overview
• 83: Myriad Genetics Inc. - Business segments
• 84: Myriad Genetics Inc. - Key offerings
• 85: Myriad Genetics Inc. - Key customers
• 86: Myriad Genetics Inc. - Segment focus
• 87: QIAGEN NV - Overview
• 88: QIAGEN NV - Business segments
• 89: QIAGEN NV - Key offerings
• 90: QIAGEN NV - Key customers
• 91: QIAGEN NV - Segment focus
• 92: Thermo Fisher Scientific Inc. - Overview
• 93: Thermo Fisher Scientific Inc. - Business segments
• 94: Thermo Fisher Scientific Inc. - Key offerings
• 95: Thermo Fisher Scientific Inc. - Key customers
• 96: Thermo Fisher Scientific Inc. - Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations

Companies Mentioned
. Abbott Laboratories
. Agilent Technologies Inc.
. Becton
. Dickinson and Co.
. bioMerieux SA
. F. Hoffmann-La Roche Ltd.
. Hologic Inc.
. Illumina Inc.
. Myriad Genetics Inc.
. QIAGEN NV
. Thermo Fisher Scientific Inc.